Results 21 to 30 of about 1,093,262 (297)

Vaccine-associated measles in a patient treated with natalizumab: a case report

open access: yesBMC Infectious Diseases, 2020
Background Safety of live vaccines in patients treated with immunosuppressive therapies is not well known, resulting in contradictory vaccination recommendations.
Alix Miauton   +4 more
doaj   +1 more source

An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses – A meeting report

open access: yesPreventive Medicine Reports, 2023
The 12th HPV Prevention and Control meeting was held on June 2–3, 2022, in Antwerp, Belgium. This technical meeting focused on several topics. This report summarises the discussions and lessons learned on two topics: an update on one-dose HPV vaccination
Dur-e-Nayab Waheed   +10 more
doaj   +1 more source

Heterogeneity in the spread and control of infectious disease: consequences for the elimination of canine rabies [PDF]

open access: yes, 2015
Understanding the factors influencing vaccination campaign effectiveness is vital in designing efficient disease elimination programmes. We investigated the importance of spatial heterogeneity in vaccination coverage and human-mediated dog movements for ...
Cleaveland, Sarah   +9 more
core   +2 more sources

Vaccines, Vaccination, and Vaccinology [PDF]

open access: yesThe Journal of Infectious Diseases, 2003
Although the demonstration in 1796 by Edward Jenner that vaccinia virus could protect against smallpox was epochal, he was following the path opened by the ancients who had used the smallpox virus itself in the practice of variolation. The work of Louis Pasteur on chicken cholera opened the way to vaccine development in the laboratory.
openaire   +2 more sources

As Vacinas Salvam Vidas? Sim, Salvam!

open access: yesActa Médica Portuguesa, 2014
Desde a sua introdução e aplicação universal, as vacinas têm sido utilizadas com sucesso reduzindo a morbilidade e mortalidade das doenças às quais se destinam, ao nível individual e através da imunidade de rebanho (imunidade colectiva).
Tinne Lernout   +3 more
doaj   +1 more source

Influence of the COVID-19 pandemic and social media on the behaviour of pregnant and lactating women towards vaccination: a scoping review

open access: yesBMJ Open, 2023
Background Pregnant women, foetuses and infants are at risk of infectious disease-related complications. Maternal vaccination is a strategy developed to better protect pregnant women and their offspring against infectious disease-related morbidity and ...
Pierre Van Damme   +5 more
doaj   +1 more source

Economic evaluation of HBV vaccination: a systematic review of recent publications (2000-2013). [PDF]

open access: yes, 2016
Aim: To conduct a systematic review of the economic evaluations (EE) of HBV vaccination, taking also into account the studies published in the new millennium. Methods: An extensive scientific literature review was conducted using two electronic medical
COLAMESTA, VITTORIA   +6 more
core   +1 more source

Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania. [PDF]

open access: yes, 2012
BACKGROUND: Cervical cancer is the leading cause of female cancer-related deaths in Tanzania. Vaccination against human papillomavirus (HPV) offers a new opportunity to control this disease.
Quentin, Wilm   +9 more
core   +5 more sources

Comparing methods of assessing dog rabies vaccination coverage in rural and urban communities in Tanzania [PDF]

open access: yes, 2017
Rabies can be eliminated by achieving comprehensive coverage of 70% of domestic dogs during annual mass vaccination campaigns. Estimates of vaccination coverage are, therefore, required to evaluate and manage mass dog vaccination programs; however, there
Changalucha, Joel   +14 more
core   +2 more sources

Human papillomavirus vaccination coverage in Luxembourg : implications of lowering and restricting target age groups [PDF]

open access: yes, 2018
Background: In Luxembourg, a national Human Papillomavirus (HPV) vaccination programme was introduced in 2008, targeting 12-17 year old girls offering a choice of bivalent or quadrivalent vaccine free of charge.
Arbyn, Marc   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy